Oral, mouse LD50 = 3700 mg/kg; Intravenous, mouse LD50 = 621 mg/kg; Oral, rabbit LD50 = 1300 mg/kg. Side effects include itching, burning, skin rash, redness, swelling, or other sign of irritation not present before use of this medicine and long-term use of sulfonamides may cause cancer of the thyroid gland.
Sulfanilamide is a molecule containing the sulfonamide functional group attached to an aniline.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Prilocaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Prilocaine. |
| Dapsone | The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Sulfanilamide. |
| Voxelotor | The serum concentration of Voxelotor can be increased when it is combined with Sulfanilamide. |
| Levamlodipine | The serum concentration of Levamlodipine can be increased when it is combined with Sulfanilamide. |
| Tramadol | The metabolism of Tramadol can be decreased when combined with Sulfanilamide. |
| Magnesium | The serum concentration of Magnesium can be decreased when it is combined with Sulfanilamide. |
| Benzylpenicillin | Sulfanilamide may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level. |
| Haloperidol | The serum concentration of Haloperidol can be increased when it is combined with Sulfanilamide. |
| Vibrio cholerae CVD 103-HgR strain live antigen | The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Sulfanilamide. |
| Estetrol | The therapeutic efficacy of Estetrol can be decreased when used in combination with Sulfanilamide. |
| Finerenone | The serum concentration of Finerenone can be increased when it is combined with Sulfanilamide. |
| Belzutifan | The serum concentration of Belzutifan can be increased when it is combined with Sulfanilamide. |
| Insulin human | The risk or severity of hypoglycemia can be increased when Sulfanilamide is combined with Insulin human. |
| Insulin lispro | The risk or severity of hypoglycemia can be increased when Sulfanilamide is combined with Insulin lispro. |
| Insulin glargine | The risk or severity of hypoglycemia can be increased when Sulfanilamide is combined with Insulin glargine. |
| Insulin pork | The risk or severity of hypoglycemia can be increased when Sulfanilamide is combined with Insulin pork. |
| Insulin aspart | The risk or severity of hypoglycemia can be increased when Sulfanilamide is combined with Insulin aspart. |
| Insulin detemir | The risk or severity of hypoglycemia can be increased when Sulfanilamide is combined with Insulin detemir. |
| Insulin glulisine | The risk or severity of hypoglycemia can be increased when Sulfanilamide is combined with Insulin glulisine. |
| NN344 | The risk or severity of hypoglycemia can be increased when Sulfanilamide is combined with NN344. |
| Insulin beef | The risk or severity of hypoglycemia can be increased when Sulfanilamide is combined with Insulin beef. |
| Insulin degludec | The risk or severity of hypoglycemia can be increased when Sulfanilamide is combined with Insulin degludec. |
| Insulin argine | The risk or severity of hypoglycemia can be increased when Sulfanilamide is combined with Insulin argine. |
| Insulin peglispro | The risk or severity of hypoglycemia can be increased when Sulfanilamide is combined with Insulin peglispro. |
| Insulin tregopil | The risk or severity of hypoglycemia can be increased when Sulfanilamide is combined with Insulin tregopil. |
| Roflumilast | The serum concentration of Roflumilast can be increased when it is combined with Sulfanilamide. |
| Enzalutamide | The serum concentration of Enzalutamide can be increased when it is combined with Sulfanilamide. |
| Chloroprocaine | The therapeutic efficacy of Sulfanilamide can be decreased when used in combination with Chloroprocaine. |
| Lidocaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Lidocaine. |
| Ropivacaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Ropivacaine. |
| Bupivacaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Bupivacaine. |
| Cinchocaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Cinchocaine. |
| Dyclonine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Dyclonine. |
| Procaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Procaine. |
| Proparacaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Proparacaine. |
| Meloxicam | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Meloxicam. |
| Oxybuprocaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Oxybuprocaine. |
| Cocaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Cocaine. |
| Mepivacaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Mepivacaine. |
| Levobupivacaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Levobupivacaine. |
| Diphenhydramine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Diphenhydramine. |
| Benzocaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Benzocaine. |
| Phenol | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Phenol. |
| Tetrodotoxin | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Tetrodotoxin. |
| Benzyl alcohol | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Benzyl alcohol. |
| Capsaicin | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Capsaicin. |
| Etidocaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Etidocaine. |
| Articaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Articaine. |
| Tetracaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Tetracaine. |
| Propoxycaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Propoxycaine. |
| Pramocaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Pramocaine. |
| Butamben | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Butamben. |
| Butacaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Butacaine. |
| Oxetacaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Oxetacaine. |
| Ethyl chloride | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Ethyl chloride. |
| Butanilicaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Butanilicaine. |
| Metabutethamine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Metabutethamine. |
| Quinisocaine | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Quinisocaine. |
| Dronabinol | The serum concentration of Dronabinol can be increased when it is combined with Sulfanilamide. |
| Cisatracurium | Sulfanilamide may increase the neuromuscular blocking activities of Cisatracurium. |
| Clozapine | The serum concentration of Clozapine can be increased when it is combined with Sulfanilamide. |
| Doxorubicin | The serum concentration of Doxorubicin can be increased when it is combined with Sulfanilamide. |
| Ambroxol | The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Ambroxol. |
| Fecal microbiota | The therapeutic efficacy of Fecal microbiota can be decreased when used in combination with Sulfanilamide. |
| Fluticasone furoate | The serum concentration of Fluticasone furoate can be increased when it is combined with Sulfanilamide. |
| Gepirone | The serum concentration of Gepirone can be increased when it is combined with Sulfanilamide. |
| Insulin icodec | The risk or severity of hypoglycemia can be increased when Sulfanilamide is combined with Insulin icodec. |